Illumina introduces iSelect custom genotyping products

The iSelect custom genotyping products allow researchers to draw on the latest advances from genome-wide association studies, next-generation whole-genome sequencing, and exome sequencing studies for variant confirmation, fine mapping, and target validation.

iSelect custom genotyping arrays provide accurate data, flexible design, relevant custom content and cost-effective genotyping, while delivering flexibility in plexity, pricing, and content that applied markets need to transition to the latest genomic tools.

Illumina Life Sciences general manager Christian Henry said the next generation iSelect custom genotyping will generate data at a lower price that will make itsInfinium assay available to a market segment not able to access it previously.

"This feature is unique to Illumina’s custom high-density arrays and provides a significant benefit to customers who want to add newly discovered content after the initial design period is completed.

"We are especially excited about the product’s new add-on content capabilities, which will allow customers to design new content for their existing custom arrays using markers found through ongoing GWAS and sequencing efforts," Henry said.